C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
12/2004
12/23/2004	WO2004111057A1 Thienopyrimidine derivatives as potassium channel inhibitors
12/23/2004	WO2004111042A1 N-heterocyclyl phenyl-substituted cyclic ketoenols
12/23/2004	WO2004111013A1 Hepatitis c virus inhibitors
12/23/2004	WO2004110459A1 Thiophenepyrimidinones as 17-beta-hydroxysteroid dehydrogenase inhibitors
12/23/2004	WO2004074270A3 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
12/23/2004	US20040260110 Coupling methyl (R)-2-(R1OSO2)-2-(2-chlorophenyl)acetates with 2-(thien-2-yl)ethylamine, concurrent or successive formylation and cyclization to form methyl (S)-2(2-chlorophenyl)-2-(4,5,6,7-tetrahydrothieno[3,2-c]-5-pyridyl)acetate (clopidrogrel)
12/23/2004	US20040256616 Process of preparing a disubstituted 9-alkylidenefluorene or a derivative thereof
12/23/2004	US20040255397 Compounds derived from diaminopyrazole substituted by a heteroaromatic radical and their use in oxidation dyeing of keratimous fibers
12/23/2004	DE10323701A1 Verfahren zur Synthese heterocyclischer Verbindungen Process for the synthesis of heterocyclic compounds
12/23/2004	CA2528888A1 N-heterocyclylphenyl-substituted cyclic ketoenols
12/23/2004	CA2527851A1 Hepatitis c virus inhibitors
12/23/2004	CA2527591A1 Thiophenepyrimidinones as 17-beta-hydroxysteroid dehydrogenase inhibitors
12/23/2004	CA2526217A1 Heteroaryl-fused pyrimidinyl compounds as anticancer agents
12/22/2004	EP1487841A1 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
12/22/2004	EP1487798A1 Substituted tetrahydroisoquinolines as c5a receptor modulators
12/22/2004	EP1189907B1 Thienopyrimidines as phosphodiesterase inhibitors
12/22/2004	EP1161555A4 4-(4-hydroxystyryl)pyridine-containing substrates for an analyte dependent enzyme activation system
12/22/2004	CN1556811A 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
12/21/2004	US6833456 Indolyl-urea derivatives of thienopyridines useful as antiangiogenic agents, and methods for their use
12/21/2004	US6833374 Dihydropyrazolo[3,4-d]thieno[2,3-B]pyridinone inhibitors of B7-1
12/16/2004	WO2004108665A2 A process for preparation of clopidogrel
12/16/2004	WO2004096805A9 Lyotropic liquid crystal systems based on sulfonated perylenetetracarboxylic acid dibenzimidazoles
12/16/2004	WO2004065390A8 Process and intermediates for the preparation of olanzapine
12/16/2004	US20040254200 Antiinflammatory agents; controlling interleukins, tumor necrosis factor; antiarthritic agents; immunosuppressants
12/16/2004	US20040254198 Respiratory system disorders; asthma; chronic obstructive pulmonary disease
12/16/2004	CA2524376A1 Substituted imidazolopyrazine and triazolopyrazyne derivatives: gabaa receptor ligands
12/15/2004	EP1485390A1 Bicyclic pyridine and pyrimidine p38 kinase inhibitors
12/15/2004	EP1485372A2 Bicyclic fused pyridinyl amides and advantageous compositions thereof for use as fungicides
12/15/2004	EP1409476B1 Pharmaceutical compounds with serotonin receptor activity
12/15/2004	EP1301517B1 Thienopyrrolidinones
12/15/2004	EP1226122B1 Bicyclic vasopressin agonists
12/15/2004	CN1555379A Spirocyclic-6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
12/15/2004	CN1555375A Compounds for inhibiting the release of inflammatory cytokines
12/15/2004	CN1179952C Pyrimidine-4-one derivatives as LDL-PLA2 inhibitors
12/15/2004	CN1179944C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
12/14/2004	US6831083 Pyrazoline derivative or tetrahydropyridazine derivative and medicinal use thereof
12/14/2004	US6831081 Herpes virus including simplex types 1 and 2, varicella zoster, human cytomegalovirus, Epstein-Barr and human 6, 7 and 8
12/09/2004	WO2004106345A2 Heteroaryl-ethanolamine derivatives as antiviral agents
12/09/2004	WO2004106344A2 Salts of clopidogrel and process for preparation
12/09/2004	US20040249162 From a pyrrolidinone compound; coloring high molecular weight material
12/09/2004	US20040248927 Preventive agent/remedial agent for constipation predominant ibs
12/09/2004	US20040248925 Use of 4-phenyl substituted tetrahydroisoquinolines in the treatment of pain, migraine and urinary incontinence
12/09/2004	US20040248904 New piperidinylamino-thieno[2,3-d] pyrimidine compounds
12/08/2004	EP1483271A1 Heterocyclic amide derivatives having glycogen phosphorylase inhibitory activity
12/08/2004	EP1483270A1 Heterocyclic amide derivatives as inhibitors of glycogen phosphorylase
12/08/2004	EP1483269A1 Racemization and enantiomer separation of clopidogrel
12/08/2004	EP1483268A2 Indolyl-urea derivatives of thienopyridines useful as anti-angiogenic agents
12/08/2004	EP1483254A1 Resistance-repellent retroviral protease inhibitors
12/08/2004	EP1363898A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/08/2004	EP1119548B1 3-(3-chloro-4-hydroxyphenylamino)-4-(2-nitrophenyl)-1h-pyrrole-2,5-dione as glycogen synthase kinase-3 inhibitor (gsk-3)
12/08/2004	EP0831094B1 Fused polycyclic heterocycle derivatives
12/08/2004	CN1553913A Process for the direct preparation of pyrrolo [3,4-c]pyrroles
12/08/2004	CN1553912A Process for the preparation of diketopyrrolopyrroles
12/07/2004	US6828343 Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors
12/07/2004	US6828329 Aryl fused substituted 4-oxy-pyridines
12/07/2004	US6828319 Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof
12/02/2004	WO2004103976A2 Method for synthesising heterocyclic compounds from thiourea derivatives
12/02/2004	WO2003064387A3 Substituted indoles as alpha-1 agonists
12/02/2004	US20040242884 3-Substituted-7-oxo-4,7-dihydro-thieno(3,2-b)pyridine-6-carboxylic acid benzylamide derivatives; for herpes viruses
12/02/2004	US20040242883 Thieno[3,2-b]pyridine-6-carbonitriles and thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors
12/02/2004	US20040242664 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
12/02/2004	US20040242660 Combinations of oxazolidinones with other active ingredients for the prophylaxis and/or treatment of thromboembolic disorders
12/02/2004	US20040242652 Beta benzyloxyaspartate derivatives with amino group on benzene ring
12/02/2004	US20040242577 N-methyl 2-morpholine-4-carbonyl or sulfonyl substituted; for example: 2-{[4-(3,4-dichlorophenoxy)piperidin-1-yl]methyl}morpholine; useful for treating asthma and/or rhinitis
12/02/2004	US20040242560 Process for synthesizing heterocyclic compounds
12/02/2004	DE10322077A1 New affinity marker compounds, useful in isotopically labeled form as reagents for mass spectroscopic analysis of proteins, comprise affinity ligand, carbohydrate linker and protein-reactive group
12/02/2004	CA2526646A1 Method for synthesising heterocyclic compounds from thiourea derivatives
12/01/2004	EP1481975A1 Inhibitors of farnesyl protein transferase
12/01/2004	EP1480985A1 Salt of benzosulfonic acid containing clopidogrel and use thereof for the production of pharmaceutical formulations
12/01/2004	EP1480959A1 Piperazine derivatives as anti-inflammatory agents
12/01/2004	EP1480647A1 Mono-ester and asymmetrically substituted di-ester pro-drugs of the dopamine d1 receptor agonists
12/01/2004	EP1480645A1 Inhibitors of tubulin polymerization
12/01/2004	EP1104407B1 Compounds as selective agonists at alpha 2b or 2b/2c adrenergic receptors
12/01/2004	CN1551884A Thieno 2,3-d]pyrimidines with combined LH and FSH agonistic activity
12/01/2004	CN1551883A Glycine-substituted thieno 2,3-d]pyrimidines with combined LH and FSH agonistic activity
12/01/2004	CN1177848C Bicyclic heteroaromatic compounds useful as LH agonists
11/2004
11/30/2004	US6825357 3,4-(1',2'-benzodioxy)thiophene monomers of given formula; electroconductive polymers
11/30/2004	US6825228 To treat infections by gram-positive bacteria, in particular drug- resistant strains
11/30/2004	US6825176 Synthesis and use of a probe that binds with specificity to the transactivation domain (tad) of human papillomavirus (hpv) e2 to form a complex, which is capable of being displaced by inhibitors of hpv
11/25/2004	WO2004101570A1 Sulfur-containing naphthoylimide derivatives
11/25/2004	WO2004101553A1 BENZIMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
11/25/2004	WO2004100947A2 Novel chemical compounds
11/25/2004	WO2004069149A3 Pharmaceutical compositions comprising thieno[2,3-c]pyridine derivatives and use thereof
11/25/2004	US20040236115 Synthesis of cyclopentadiene derivatives
11/25/2004	US20040235990 Electrolytes and electroconductors for capacitors for multilayer element and smoothness for light emitting diodes and electroconductive elements
11/25/2004	US20040235884 increasing choline transporters on the cell membrane of nervous systems by administering drugs such as 2-(2-oxopyrrolidin-1-yl)-N-(2,3dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4yl)acetamide; prophylaxis of nervous system disorders
11/25/2004	US20040235867 Drugs used for signal transduction modulation, and for prophylaxis of angiogenesis, cancers, tumors, atherosclerosis, vision disorders and inflammatory diseases in mammals
11/25/2004	US20040235753 Oxytocin agonists
11/25/2004	CA2526065A1 Benzimidazole-derivatives as factor xa inhibitors
11/24/2004	EP1479684A1 Thienopyrimidines, process for preparing the same and use thereof
11/24/2004	EP1479676A1 Benzimidazole-derivatives as factor xa inhibitors
11/24/2004	EP1478645A2 Quinolinone derivatives for treating cell proliferation related disorders
11/24/2004	EP1478634A1 Furanone derivatives
11/24/2004	EP1478628A1 2-amino-4-bicyclyl amino-6h-1.3.5-triazines, method for the production and use thereof as herbicides and plant growth regulators
11/24/2004	EP1478357A2 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
11/24/2004	CN1549812A Pyrazole compounds useful as protein kinase inhibitors.
11/24/2004	CN1548440A Production process of hexahydrothiophene-[3,4-d] imidazolyl-2,4-dikitone
11/23/2004	US6822384 Design and synthesis of advanced NLO materials for electro-optic applicators
11/23/2004	US6822097 Compounds and methods of uses
11/23/2004	US6821977 Antidiabetic agents

1 ... 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 ... 214